業績 2018

Sagami R, Nishikiori H, Anami K, Fujiwara S, Honda K, Ikuyama S, Kitano M, Murakami K
Utility of Endoscopic Ultrasonography Screening for Small Pancreatic Cancer and Proposal for a New Scoring System for Screening.
Pancreas, 47(2), 257-264, 2018

Kodama M, Okimoto T, Mizukami K, Abe H, Ogawa R, Okamoto K, Shuto M, Matsunari O, Hirashita Y, Sato R, Abe T, Nagai T, Arita T, Murakami K.
Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication.
Digestion, 97(4), 288-297, 2018 Mar 7

Inoue K, Okajima T, Okamoto O, Murakami K.
Bullous Pemphigoid Presenting with Esophagitis Dissecans Superficialis.
Intern Med, 57(1), 141-142, 2018

Chayama K, Suzuki F, Karino Y, Kawakami Y, Sato K, Atarashi T, Naganuma A, Watanabe T, Eguchi Y, Yoshiji H, Seike M, Takei Y, Kato K, Alves K, Burroughs M, Redman R, Pugatch DL, Pilot-Matias TJ, Krishnan P, Oberoi RK, Xie W, Kumada H.
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
J Gastroenterol, 53(4), 557-565, 2018

Rolt A, Le D, Hu Z, Wang AQ, Shah P, Singleton M, Hughes E, Dulcey AE, He S, Imamura M, UchidaT, Chayama K, Xu X, Marugan JJ, Liang TJ.
Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
J Infect Dis, 217(11), 1761-1769, 2018

Kato M, Uedo N, Hokimoto S, Ieko M, Higuchi K, Murakami K, Fujimoto K
Guidelines for Gastroenterological Endoscopy in Patients Undergoing Antithrombotic Treatment: 2017 Appendix on Anticoagulants Including Direct Oral Anticoagulants.
Dig Endosc, 30(4), 433-440, 2018


Tsutsumi K, Kusano C, Suzuki S, Gotoda T, Murakami K
Diagnostic Accuracy of Latex Agglutination Turbidimetric Immunoassay in Screening Adolescents for Helicobacter pylori Infection in Japan.
Digestion, 98(2), 75-80, 2018

Togo K, Ueo T, Yao K, Wada K, Honda H, Inoue S, Fukuda M, Yanai Y, Yonemasu H, Murakami K
White opaque substance visualized by magnifying narrow-band imaging is associated with intragastric acid conditions.
Endosc Int Open, 6(7), 830-837, 2018

Nagahama T, Yao K, Uedo N, Doyama H, Ueo T, Uchita K, Ishikawa H, Kanesaka T, Takeda Y, Wada K, Imamura K, Arima H, Shimokawa T.
Delineation of the extent of early gastric cancer by magnifying narrow-band imaging and chromoendoscopy: a multicenter randomized controlled trial.
Endoscopy, 50(6), 566-576, 2018

Fukuda M, Ishigaki H, Ban H, Sugimoto M, Tanaka E, Yonemaru J, Kuroe S, Namura T, Matsubara A, Moritani S, Murakami K, Andoh A, Kushima R
No transformation of a fundic gland polyp with dysplasia into invasive carcinoma after 14 years of follow-up in a proton pump inhibitor-treated patient: A case report.
Pathol Int, 68(12), 706-711, 2018

Sonoda A, Kamiyama N, Ozaka S, Gendo Y, Ozaki T, Hirose H, Noguchi K, Saechue B, Sachi N, Sakai K, Mizukami K, Hidano S, Murakami K, Kobayashi T
Oral administration of antibiotics results in fecal occult bleeding due to metabolic disorders and defective proliferation of the gut epithelial cell in mice.
Genes Cells, 23(12), 1043-1055, 2018

Inoue H, Shiwaku H, Iwakiri K, Onimaru M, Kobayashi Y, Minami H, Sato H, Kitano S, Iwakiri R, Omura N, Murakami K, Fukami N, Fujimoto K, Tajiri H
Clinical practice guidelines for peroral endoscopic myotomy.
Dig Endosc, 30(5), 563-579, 2018

Kikuchi S, Kato M, Mabe K, Kawai T, Furuta T, Inoue K, Ito M, Yoshihara M, Kodama M, Murakami K
Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection.
J Epidemiol, [Epub ahead of print], 2018

Saito T, Niida A, Uchi R, Hirata H, Komatsu H, Sakimura S, Hayashi S, Nambara S, Kuroda Y, Ito S, Eguchi H, Masuda T, Sugimachi K, Tobo T, Nishida H, Daa T, Chiba K, Shiraishi Y, Yoshizato T, Kodama M, Okimoto T, Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Matsui Y, Shimamura T, Hasegawa T, Doki Y, Nagayama S, Yamada K, Kato M, Shibata T, Mori M, Aburatani H, Murakami K, Suzuki Y, Ogawa S, Miyano S, Mimori K
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
Nat Commun, 9(1), 2884, 2018

Kawaguchi T, Tokushige K, Hyogo H, Aikata H, Nakajima T, Ono M, Kawanaka M, Sawada K, Imajo K, Honda K, Takahashi H, Mori K, Tanaka S, Seko Y, Nozaki Y, Kamada Y, Fujii H, Kawaguchi A, Takehara T, Yanase M, Sumida Y, Eguchi Y, Seike M, Yoneda M, Suzuki Y, Saibara T, Karino Y, Chayama K, Hashimoto E, George J, Torimura T
A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.
Sci Rep, 8(1), 10434, 2018

Hidaka H, Kurosaki M, Tanaka H, Kudo M, Abiru S, Igura T, Ishikawa T, Seike M, Katsube T, Ochiai T, Kimura K, Fukuhara T, Kano T, Nagata T, Tanaka K, Kurokawa M, Yamamoto K, Osaki Y, Izumi N, Imawari M.
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.
Clin Gastroenterol Hepatol, S1542-3565(18)31324-7, 2018, [Epub ahead of print]

Masuda K, Ono A, Aikata H, Kawaoka T, Nelson Hayes C, Teraoka Y, Daijo K, Nakamura-Inagaki Y, Morio K, Fujino H, Kan H, Uchida T, Masaki K, Kobayashi T, Nakahara T, Makokha GN, Zhang Y, Nagaoki Y, Miki D, Tsuge M, Hiramatsu A, Imamura M, Abe-Chayama H, Kawakami Y, Ochi H, Chayama K.
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
J Gastroenterol, 53(1), 107-118, 2018

Kurihara M, Tsuge M, Murakami E, Mori N, Ohishi W, Uchida T, Fujino H, Nakahara T, Abe-Chayama H, Kawaoka T, Miki D, Hiramatsu A, Imamura M, Kawakami Y, Aikata H, Ochi H, Zhang Y, Makokha GN, Hayes CN, Chayama K.
The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients.
Antivir Ther, 23(3), 239-248, 2018

Tamura T, Fukuhara T, Uchida T, Ono C, Mori H, Sato A, Fauzyah Y, Okamoto T, Kurosu T, Setoh YX, Imamura M, Tautz N, Sakoda Y, Khromykh AA, Chayama K, Matsuura Y.
Characterization of recombinant Flaviviridae viruses possessing a small reporter-tag.
J Virol, 92(2), 2018

Rolt A, Le D, Hu Z, Wang AQ, Shah P, Singleton M, Hughes E, Dulcey AE, He S, Imamura M, Uchida T, Chayama K, Xu X, Marugan JJ, Liang TJ.
Preclinical Pharmacological Development of Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
J Infect Dis, 217(11), 1761-1769, 2018

Teraoka Y, Uchida T, Imamura M, Osawa M, Tsuge M, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Miki D, Ochi H, Ishida Y, Tateno C, Chayama K; Hiroshima Liver Study Group.
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice.
Biochem Biophys Res Commun. 500(2), 152-157, 2018

Furuta M, Tanaka H, Shiraishi Y, Uchida T, Imamura M, Fujimoto A, Fujita M, Sasaki-Oku A, Maejima K, Nakano K, Kawakami Y, Arihiro K, Aikata H, Ueno M, Hayami S, Ariizumi SI, Yamamoto M, Gotoh K, Ohdan H, Yamaue H, Miyano S, Chayama K, Nakagawa H.
Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers.
Oncotarget, 9(38), 25075-25088, 2018

Teraoka Y, Uchida T, Imamura M, Hiraga N, Osawa M, Kan H, Saito Y, Tsuge M, Abe-Chayama H, Hayes CN, Makokha GN, Aikata H, Miki D, Ochi H, Ishida Y, Tateno C, Chayama K.
Limitation of asunapurevir, daclatasvir plus beclabuvir treatment in NS5A inhibitor treatment failures.
J Gen Virol, 99(8), 1058-1065, 2018

Tatsukawa Y, Tsuge M, Kawakami Y, Murakami E, Kurihara M, Nomura M, Tsushima K, Uchida T, Nakahara T, Miki D, Kawaoka T, Abe-Chayama H, Imamura M, Aikata H, Ochi H, Hayes CN, Kawakami H, Chayama K.
Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study.
Antivir Ther, [Epub ahead of print], 2018

Nomura M, Tsuge M, Uchida T, Hiraga N, Kurihara M, Tsushima K, Fujino H, Nakahara T, Murakami E, Abe-Chayama H, Kawaoka T, Miki D, Hiramatsu A, Imamura M, Kawakami Y, Aikata H, Ochi H, Zhang Y, Makokha GN, Hayes CN, Tanaka S, Chayama K.
CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients.
J Viral Hepat, 25(12), 1555-1564, 2018

Tsuge M, Hiraga N, Zhang Y, Yamashita M, Sato O, Oka N, Shiraishi K, Izaki Y, Makokha GN, Uchida T, Kurihara M, Nomura M, Tsushima K, Nakahara T, Murakami E, Abe-Chayama H, Kawaoka T, Miki D, Imamura M, Kawakami Y, Aikata H, Ochi H, Hayes CN, Fujita T, Chayama K.
Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes.
Virology. 18(525), 48-61, 2018

Osawa M, Imamura M, Teraoka Y, Uchida T, Morio K, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Aikata H, Hayes CN, Chayama K; Hiroshima Liver Study Group.
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.
J Gastroenterol, [Epub ahead of print], 2018

Harada H, Murakami D, Suehiro S, Nakahara R, Ujihara T, Sagami R, Katsuyama Y, Hayasaka K, Amano Y.
Water-pocket endoscopic submucosal dissection for superficial gastric neoplasms (with video).
Gastrointest Endosc, Aug;88(2), 253-260, 2018

Ogura T, Kitano M, Takenaka M, Okuda A, Minaga K, Yamao K, Yamashita Y, Hatamaru K, Noguchi C, Gotoh Y, Kuroda T, Yokota T, Nishikiori H, Sagami R, Higuchi K, Chiba Y.
Multicenter prospective evaluation study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting (with video).
Dig Endosc, 30(2), 252-259, 2018

村上和成
消化器系に作用する薬剤 消化管運動機能改善薬・消化性潰瘍治療薬・腸疾患治療薬・痔疾患治療薬・下剤
今日の治療薬 解説と便覧 2018, 746-808, 2018

沖本忠義、村上和成
【上部消化管疾患 ピロリ菌陰性時代への過渡期をむかえて】 治療 
実地医家が知っておくべき治療の進歩とその着目点 
ヘリコバクター・ピロリ除菌治療の現状と将来展望
Medical Practice, 35(1), 129-133, 2018

小川竜、村上和成 総説

  1. pylori感染胃炎 H. pylori感染の診断と治療のガイドライン2016改訂版

診療ガイドラインUP-TO-DATE 20182019, 236-241, 2018

清家正隆
【肝癌-診断・治療の最新知見-】 肝癌の主な病因とその治療 アルコール性肝障害と肝癌
日本臨床, 76(2), 287-296, 2018

沖本忠義
P-CABを用いたHelicobacter pylori除菌率
一次除菌率がPPIを用いたそれに比べて高い理由は?
二次除菌率がPPIを用いたそれと変わらない理由は?
Helicobacter Research, 22(1), 66-69, 2018

兒玉雅明、沖本忠義、小川竜、岡本和久、水上一弘、村上和成
【日本ヘリコバクター学会主導の全国除菌レジストリー(登録調査)
世界の類似研究との差異 欧米とアジア
Helicobacter Research, 22(1), 48-55, 2018

阿部寿徳、橋永正彦、相馬渉、武原真一、村上和成
便潜血陽性により発見された無症候性大腸魚骨の1(原著論文/症例報告)
内科 Internal medicine, 353-355, 121(2), 2018

兒玉雅明
Ⅸ 脳卒中の人を支える地域包括ケア
脳卒中の医学的知識の概要
やわらかアカデミズム・〈わかる〉シリーズ よくわかる地域包括ケア, 140-141, 2018

兒玉雅明
Ⅺ がんの人を支える地域包括ケア
がんの医学的知識の概要
やわらかアカデミズム・〈わかる〉シリーズ よくわかる地域包括ケア, 186-187, 2018

兒玉雅明、沖本忠義、小川竜、岡本和久、水上一弘、村上和成
【日本ヘリコバクター学会主導の全国除菌レジストリー(登録調査)
世界の類似研究との差異 欧米とアジア
Helicobacter Research, 22(1), 48-55, 2018

河合隆、伊藤公訓、青山伸郎、村上和成、加藤勝章、大泉晴史、古田隆久、笹島雅彦、吉村理江、伊藤愼芳、青木利佳、岡政志、安田貢、山道信毅、杉山敏郎、日本ヘリコバクター学会胃がんリスク評価に資する抗体法適正化委員
胃がんリスク評価に資する抗体法適正化に関する多施設研究
日本ヘリコバクター学会誌, 19(2), 133-138, 2018

松成修、村上和成
【先制医療-予防医療の最前線-】 先制医療・予防医療の実際 ピロリ菌除菌と除菌後指導
診断と治療, 106(1), 29-33, 2018

井上晴洋、塩飽洋生、岩切勝彦、鬼丸学、小林泰俊、南ひとみ、佐藤裕樹、北野正剛、岩切龍一、小村伸朗、村上和成、深見悟生、藤本一眞、田尻久雄
POEM 診療ガイドライン
日本消化器内視鏡学会雑誌, 60(6, 1249-1271, 2018

上尾哲也, 都甲和美, 本田秀穂, 米増博俊, 井上翔太郎, 安部雄治, 和田蔵人, 田邉寛, 八尾建史, 岩下明德, 村上和成
【胃拡大内視鏡が変えたclinical practiceNBI拡大観察が有用であった散発性胃底腺ポリープ癌化の2
胃と腸, 53(11), 1529-1535, 2018
兒玉雅明、村上和成
ピロリ菌除菌後のPPI長期使用における異時性胃癌
早期胃癌がみえる!見落とさない! 胃内視鏡検査・診断に自信がつく本, 225-227, 2018

山崎 侑子(大分大学 医学部内分泌代謝・膠原病・腎臓内科学講座), 中田 健, 丸尾 美咲, 内田 大貴, 楢原 秀雄, 鈴木 美穂, 緒方 歩美, 川原 有希子, 安東 加恵, 石田 楓, 工藤 明子, 橋永 絵理, 青木 宏平, 東 寛子, 縄田 智子, 本田 俊一郎, 本田 浩一, 山本 俊介, 後藤 孝治, 福長 直也, 村上 和成, 北野 敬明, 柴田 洋孝
III度熱中症にDIC・急性肝不全を合併し、血漿交換(PE)および持続血液濾過透析(CHDF)を施行した1(原著論文)
日本透析医学会雑誌 (1340-3451)519 Page539-544(2018.09)

水上一弘、阿部寿徳、後藤康彦、渕野貴文、福田健介、松成修、岡本和久、小川竜、沖本忠義、兒玉雅明、村上和成
逆流性食道炎患者におけるプロトンポンプ阻害薬の内視鏡的治癒および症状改善効果の検討(原著論文)
Therapeutic Research, 39(8), 685-690, 2018

山崎侑子, 中田健, 丸尾美咲, 内田大貴, 楢原秀雄, 鈴木美穂, 緒方歩美, 川原有希子, 安東加恵, 石田楓, 工藤明子, 橋永絵理, 青木宏平, 東寛子, 縄田智子, 本田俊一郎, 本田浩一, 山本俊介, 後藤孝治, 福長直也, 村上和成, 北野敬明, 柴田洋孝
III度熱中症にDIC・急性肝不全を合併し、血漿交換(PE)および持続血液濾過透析(CHDF)を施行した1(原著論文)
日本透析医学会雑誌, 51(9), 539-544, 2018
 
和田康宏、村上和成
まとめてみました 最近気になること PPIの効果的な服用のタイミング
日本医事新, 4939, 10-11, 2018